{"name": "Affimed Therapeutics",
 "permalink": "affimed-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/affimed-therapeutics",
 "homepage_url": "http://www.affimed.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@affimed.com",
 "phone_number": "+49-(0)6221-65307-0",
 "description": "",
 "created_at": "Wed May 05 07:05:47 UTC 2010",
 "updated_at": "Wed May 05 07:01:33 UTC 2010",
 "overview": "\u003Cp\u003EAffimed Therapeutics AG, a biopharmaceutical company, engages in the discovery and development of recombinant antibody therapeutics for the treatment of cancer and other diseases. It offers TandAbs, a tetravalent antibody that is targeting tumor cells. The company also provides programs for treatment of Non-Hodgkin\u00e2\u20ac\u2122s Lymphoma, Hodgkin\u00e2\u20ac\u2122s diseases, thrombosis and autoimmune, leukemia, myeloma, solid tumors, metastasis, non-cancer indications, allergy, and asthma diseases. Affimed Therapeutics AG was founded in 2000 and is headquartered in Heidelberg, Germany.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0008/6010/86010v1-max-150x150.png"],
     [[234,
       65],
      "assets/images/resized/0008/6010/86010v1-max-250x250.png"],
     [[234,
       65],
      "assets/images/resized/0008/6010/86010v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Rolf",
      "last_name": "H. G\u00c3\u00bcnther",
      "permalink": "rolf-h-gnther",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Florian",
      "last_name": "Fischer",
      "permalink": "florian-fischer-2",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac20M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.fiercebiotech.com/story/affimed-raises-20m-fund-innovative-antibody-trials/2010-04-29",
    "source_description": "Affimed raises \u00e2\u201a\u00ac20M to fund innovative antibody trials",
    "raised_amount": 20000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Aeris Capital",
         "permalink": "aeris-capital",
         "image":
          {"available_sizes":
            [[[150,
               80],
              "assets/images/resized/0002/1174/21174v1-max-150x150.jpg"],
             [[250,
               134],
              "assets/images/resized/0002/1174/21174v1-max-250x250.jpg"],
             [[450,
               242],
              "assets/images/resized/0002/1174/21174v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BioMedinvest",
         "permalink": "biomedinvest",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0005/0483/50483v3-max-150x150.png"],
             [[250,
               41],
              "assets/images/resized/0005/0483/50483v3-max-250x250.png"],
             [[266,
               44],
              "assets/images/resized/0005/0483/50483v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo Nordisk",
         "permalink": "novo-nordisk",
         "image":
          {"available_sizes":
            [[[70,
               49],
              "assets/images/resized/0004/9782/49782v1-max-150x150.png"],
             [[70,
               49],
              "assets/images/resized/0004/9782/49782v1-max-250x250.png"],
             [[70,
               49],
              "assets/images/resized/0004/9782/49782v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Technologiepark",
    "address2": "Im Neuenheimer Feld 582",
    "zip_code": "69120 ",
    "city": "Heidelberg",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}